Enteric microflora in IBD: Pathogens or commensals?

Inflammatory Bowel Diseases

Volumn 3, Issue 3, 1997, Pages 230-235

  Sartor, R Balfour ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Crohn's disease; Inflammation; Lumen; Microflora

Indexed keywords

EID: 0000153298     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780030309     Document Type: Review

References (44)

1. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-508.
2. Sartor RB. Insights into the pathogenesis of inflammatory bowel diseases provided by new rodent models of spontaneous colitis. Inflammatory Bowel Diseases 1995;1:64-75.
3. Sartor RB. Microbial factors in the pathogenesis of Crohn's disease, ulcerative colitis and experimental intestinal inflammation. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease, 4th ed. Baltimore: Williams & Wilkins, 1995:96-124.
4. Chadwick VS, Anderson RP. Microorganisms and their products in inflammatory bowel disease. In: MacDermott RP, Stenson WF, eds. Inflammatory bowel disease. New York: Elsevier, 1992, 241-58.
5. Rath HC, Sellon RK, Sartor RB. Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 1996;12:327-33.
6. Schultz M, Sartor RB. Aberrant host responses to luminal bacteria in the pathogenesis of chronic intestinal inflammation. In: Ernst PB, Michetti P, Smith PD, eds. The immunobiology of H. pylori. Philadelphia: Lippincott-Raven, 1997:67-82.
7. Blaser MJ. Microbial causation of the chronic idiopathic inflammatory bowel diseases. Inflammatory Bowel Diseases 1997;3: 225-9.
8. Sartor RB. Workshop XI: Mycobacterium paratuberculosis in Crohn's disease. In: Tytgat GNJ, Bartelsman JFWM, VanDeventer SJH, eds. Inflammatory bowel diseases. Dordrecht, the Netherlands: Kluwer Academic Press, 1995:425-8.
9. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of listeria, Escherichia coli, and streptococcus antigens in Crohn's disease. Gastroenterology 1995;108:1396-404.
10. Wakefield AJ, Ekbom A, Dhilon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995;108:911-6.
11. Haga Y, Funakoshi O, Kuroe K, et al. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 1996;38:211-5.
12. Chiodini R. Crohn's disease and the mycobacterioses: A review and comparison of two disease entities. Clin Microbiol Rev 1989; 2:90-117.
13. Sanderson JD, Moss MT, Tizard ML, et al. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut 1992;33:890-6.
14. Rowbotham DS, Mapstone NP, Trejdosiewicz LK, Howdle PD, Quirke P. Mycobacterium paratuberculosis DNA not detected in Crohn's disease tissue by fluorescent polymerase chain reaction. Gut 1995;37:660-7.
15. Mishina D, Katsel P, Brown ST, Gilberts ECAM, Greenstein RJ. On the etiology of Crohn's disease. Proc Natl Acad Sci USA 1996; 93:9816-20.
16. Millar DS, Ford J, Sanderson J, et al. PCR testing for Mycobacterium paratuberculosis in units of whole unpasteurized cow's milk widely obtained from retail outlets in England and Wales. In: Chiodini RJ, Collins MT, Bassey EOE, eds. Proceedings of the Fourth International Colloquium on Paratuberculosis. Providence, RI: International Association for Paratuberculosis, 1995:320.
17. Wells CL, van de Westerlo MA, Jechorek RP, Feltis BA, Wilkins TD, Erlandsen SL. Bacteroides fragilis enterotoxin modulates epithelial permeability and bacterial internalization by HT-29 enterocytes. Gastroenterology 1996;110:1429-37.
18. Klapproth JM, Donnenberg MS, Abraham JM, Mobley HL, James SP. Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production. Infect Immun 1995;63: 2248-54.
19. Roediger WEW, Duncanb A, Kapaniris OK, et al. Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 1993;104:803-9.
20. Pitcher MCL, Beatty ER, Gibson GR, Cummings JH. Sulphate-reducing bacteria: prevalence in active and inactive ulcerative colitis. Gastroenterology 1995;108:A894.
21. Shames B, Fox JG, Dewhirst F, Yan L, Shen Z, Taylor NS. Identification of widespread Helicobacter hepaticus infection in feces in commercial mouse colonies by culture and PCR assay. J Clin Microbiol 1995;33:2968-72.
22. Schwab JH. Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun 1993;61:4535-9.
23. Sartor RB. Role of the enteric microflora in the pathogenesis of intestinal inflammation and arthritis. Aliment Pharmacol Ther (in press).
24. Sartor RB, Lichtman SN. Mechanisms of systemic inflammation associated with intestinal injury. In: Targan S, Shanahan F, eds. Inflammatory bowel disease: from bench to bedside. Baltimore: Williams & Wilkins; 1993:210-29.
25. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1994;75:252-61.
26. Sellon R, Tonkonogy S, Schultz M, Sartor RB. Absence of gastritis and colitis in germ free IL-10 knockout mice. Gastroenterology 1997;112:A1088.
27. Mombaerts P, Mizoguchi E, Grusby MJ, Glincher CH, Bhan AU, Tonegawa S. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 1993;75:274-82.
28. 27-associated human disorders. Cell 1990;63:1099-112.
29. Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm T, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human (2 microglobulin transgenic rats. J Clin Invest 1996;98:945-53.
30. Schultz M, Sellon RK, Tonkonogy SL, Balish E, Sartor RB. IL-2 deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation and progressive loss of B cells. Gastroenterology 1997;112:A1086.
31. Sutherland L, Singleton J, Sessions J. Double blind, placebo controlled trial of metronidazole in Crohn's disease. Gut 1991;32: 1071-5.
32. Turunen U, et al. A double blind, placebo controlled, six month ciprofloxacin treatment improves prognosis in ulcerative colitis. Gastroenterology 1994;106:A786.
33. Onderdonk AB, Franklin ML, Cisneros RL. Production of experimental ulcerative colitis in gnotobiotic guinea pigs with simplified microflora. Infect Immun 1981;32:225.
34. Krok A, Jarnet G, Danielsson D. Clinical effect of metronidazole and sulfasalazine on Crohn's disease in relation to changes in the fecal flora. Scand J Gastroenterol 1981;16:569-75.
35. Madsen KL, Tavernini MM, Doyle JSG, Fedorak RN. Lactobacillus SP prevents development of enterocolitis in interleukin-10 gene deficient mice. Gastroenterology 1997;112:A1030.
36. 3H/HeJ Bir mice. Gastroenterology 1996;110: A887.
37. MacPherson A, Khoo UY, Forgacs I, Philpott-Howard J, Bjarnason I. Mucosal antibodies in inflammatory bowel disease are directed against bacteria. Gut 1996;38:365-73.
38. Duchmann R, Kaiser I, Hermann E, Mayet W, Ewe K, Meyer zum Büschenfelde K-H. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin Exp Immunol 1995;1032:448-55.
39. Duchmann R, Schmitt E , Knolle P, Meyer zum Büschenfelde K-H, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26:934-8.
40. 3H/HeJ Bir mice to enteric bacteria. Gastroenterology 1994;106:A565.
41. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science 1995;270:1203-7.
42. Mashimo H, Wu DC, Podolsky DK, Fishman MC. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-5.
43. 1-like response. J Clin Invest 1996; 98:1010-20.
44. McCall RD, Haskill S, Zimmermann EM, Lund PK, Thompson RC, Sartor RB. Tissue IL-1 and IL-1 receptor antagonist expression in rat strains variably susceptible to granulomatous enterocolitis. Gastroenterology 1994;106:960-72.